AG
GSK icon

Advisor Group’s GSK GSK Stock Holding History

Advisor Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7.97M Sell
135,697
-1,056
-0.8% -$58.7K 0.06% 280
2019
Q3 		$7.3M Sell
136,753
-2,947
-2% -$152K 0.05% 302
2019
Q2 		$6.99M Buy
139,700
+4,352
+3% +$218K 0.05% 304
2019
Q1 		$7.07M Buy
135,348
+13,590
+11% +$679K 0.06% 293
2018
Q4 		$5.82M Buy
121,758
+11,435
+10% +$563K 0.06% 284
2018
Q3 		$5.54M Buy
110,323
+16,682
+18% +$848K 0.06% 293
2018
Q2 		$4.72M Sell
93,641
-1,795
-2% -$90.4K 0.06% 259
2018
Q1 		$4.66M Sell
95,436
-1,036
-1% -$48.2K 0.06% 269
2017
Q4 		$4.28M Buy
96,472
+15,513
+19% +$717K 0.06% 303
2017
Q3 		$4.11M Buy
80,959
+11,204
+16% +$568K 0.06% 274
2017
Q2 		$3.76M Buy
69,755
+8,553
+14% +$456K 0.07% 290
2017
Q1 		$3.23M Buy
61,202
+4,757
+8% +$241K 0.07% 310
2016
Q4 		$2.72M Buy
56,445
+980
+2% +$48.4K 0.06% 334
2016
Q3 		$2.99M Buy
55,465
+2,565
+5% +$141K 0.07% 296
2016
Q2 		$2.86M Buy
+52,900
New +$2.79M 0.08% 289

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Advisor Group's GSK Position: Q4 2019 in Review

Advisor Group reduced its GSK (GSK) stake by 0.77% in Q4 2019, selling an estimated $58.7K and leaving 135,697 shares worth $7.97M. The position accounts for 0.06% of the portfolio, ranked #280.

Advisor Group first reported a position in GSK in Q2 2016 and has held it in 15 quarters since. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Advisor Group held 135,697 shares of GSK worth $7.97M as of Q4 2019.
  • Advisor Group sold 1,056 GSK shares in Q4 2019, an estimated $58.7K.
  • GSK made up 0.06% of Advisor Group's portfolio in Q4 2019, its #280 holding.
  • Advisor Group first reported a position in GSK in Q2 2016 and has held it in 15 quarters since.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.